Can I Take Glycine with Fosamax (Alendronate)?

What Is the Interaction Between Glycine and Fosamax?

The core interaction concern is pharmacokinetic, not pharmacodynamic. Alendronate has notoriously poor oral bioavailability: roughly 0.6% under ideal fasting conditions, and any amino acid, mineral, food, or beverage taken within 30 minutes can chelate or compete for intestinal absorption and reduce that figure further. Glycine itself has not been shown to block bisphosphonate uptake in clinical trials, but because it is an amino acid ingested orally, the general fasting rule applies.

Why Alendronate Absorption Is So Fragile

Alendronate's absorption mechanism depends on passive paracellular transport across the upper gastrointestinal epithelium. The drug binds divalent cations readily, which is why calcium, magnesium, and iron supplements devastate its uptake [1]. Amino acids share some of the same transporter space in the proximal small intestine, and co-ingestion studies with protein beverages show absorption reductions of up to 60% [2].

The FDA-approved labeling for alendronate sodium (Fosamax) states that patients must take the tablet with plain water only, at least 30 minutes before the first food, drink, or other medication of the day [3]. Glycine powder dissolved in water counts as oral intake under that rule.

Pharmacodynamic Considerations

A pharmacodynamic interaction would mean glycine directly counteracts or amplifies alendronate's mechanism at the bone. Alendronate works by inhibiting farnesyl pyrophosphate synthase (FPPS) in osteoclasts, suppressing bone resorption [4]. Glycine has no known pathway that interferes with FPPS. Some rodent data suggest glycine may modulate osteoblast activity through the glycine receptor and mTOR signaling [5], but this is pre-clinical work and does not constitute clinical evidence of interaction with bisphosphonate therapy.

How Does Glycine Affect Bone Health on Its Own?

Glycine is worth examining separately from the interaction question because its effects on bone tissue are biologically relevant to osteoporosis patients.

Glycine and Type I Collagen

Glycine makes up roughly one-third of all amino acid residues in type I collagen, the primary structural protein of bone matrix [6]. Every third position in the collagen triple helix requires glycine (the motif is Gly-X-Y repeated throughout the chain). Without adequate glycine supply, collagen synthesis slows. Bone mineralization occurs on the collagen scaffold, so matrix quality matters alongside mineral density.

Dietary glycine intake from food averages 2 to 3 g per day in adults eating a mixed diet, but biosynthesis may not fully cover demand during periods of high collagen turnover, such as fracture healing or rapid bone remodeling [7]. Supplemental glycine at 3 g to 5 g per day has been studied for sleep quality, glycemic markers, and cartilage support, though large RCTs in osteoporosis patients specifically are lacking.

Glycine and Sleep Quality

Poor sleep quality is associated with lower bone mineral density in postmenopausal women. A 2015 study by Inagawa et al. (N=11) found that 3 g of glycine taken before bed improved subjective and objective sleep quality measures compared with placebo [8]. Sleep improvement may be an indirect benefit for alendronate users, given the sleep-bone density relationship, though no direct trial has connected glycine-induced sleep improvement to bisphosphonate outcomes.

Glycine and Glycemic Markers

Alendronate is sometimes prescribed to patients who also have type 2 diabetes, since fracture risk is elevated in that population. Glycine has a modest insulin-sensitizing effect in some data: a 2015 study in Diabetes Care showed lower fasting plasma glycine concentrations were associated with insulin resistance [9]. Whether supplemental glycine meaningfully improves glycemic control in humans remains uncertain, and it should not replace diabetes medications.

Pharmacokinetics of Alendronate: Why Timing Matters More Than Most Drugs

Alendronate has one of the most demanding oral dosing protocols of any widely prescribed medication. Getting the pharmacokinetics right is the entire clinical task.

Bioavailability Basics

Oral bioavailability under ideal conditions is approximately 0.6% for alendronate sodium tablets [3]. Compare this with metformin at roughly 50 to 60% or atorvastatin at about 12% after first-pass metabolism. Even small perturbations from the fasting window translate into disproportionately large percentage reductions in the already-tiny absorbed fraction.

A study published in the Journal of Clinical Pharmacology showed that co-administration of alendronate with orange juice reduced bioavailability by approximately 60%, and co-administration with black coffee reduced it by approximately 60% as well [10]. These beverages contain no divalent cations in relevant quantities, which indicates that even mildly acidic or amino acid-containing solutions impair absorption through mechanisms beyond simple chelation.

The 30-Minute Rule in Practice

The practical consequence: if you take your weekly 70 mg alendronate tablet with 240 mL (8 oz) of plain water at 7:00 AM, you should not take your glycine supplement until at least 7:30 AM. Many clinicians recommend waiting a full 60 minutes to build in a safety margin, particularly for patients who are taking alendronate for established osteoporosis rather than prevention, where consistent full-dose delivery matters most.

The HealthRX Bisphosphonate Supplement Timing Framework organizes this into three windows:

• Pre-dose window (avoid entirely): Any supplement within 30 min before alendronate.
• Blackout window (30 to 60 min post-dose): No food, drink, or supplements other than plain water.
• Open window (60+ min post-dose, or any other time of day): Glycine and most other supplements can be taken freely.

For weekly alendronate dosers, this represents a constraint on only a few minutes one morning per week, making compliance straightforward.

What the Evidence Says About Amino Acid Supplements and Bisphosphonates

Protein Intake and Fracture Outcomes

High protein intake is associated with better hip-fracture outcomes. A prospective cohort analysis in the Journal of Bone and Mineral Research (N=116,686 women, Nurses' Health Study) found that higher total protein intake was associated with a 69% lower risk of hip fracture over 18 years [11]. Amino acids, including glycine, are the building blocks of that protein. This suggests that alendronate users should not fear amino acid supplements from an efficacy standpoint, only from a dosing-window standpoint.

Specific Data on Glycine and Bisphosphonates

No RCT has directly studied glycine supplementation in alendronate-treated patients. That absence of evidence is not evidence of harm. The Natural Medicines Database (formerly Natural Standard) rates the glycine-alendronate interaction as having insufficient evidence to characterize risk [12], which aligns with the general pharmacological picture: glycine lacks the cation-chelating chemistry that drives the known drug-food interactions for bisphosphonates.

Collagen Peptides vs. Free Glycine

Some bone-health supplement stacks use collagen hydrolysates rather than free glycine. A 12-month RCT published in Nutrients (2018, N=102) found that 5 g per day of specific collagen peptides increased bone mineral density at the spine and femoral neck compared with placebo in postmenopausal women [13]. Collagen peptides are rich in glycine-proline-hydroxyproline sequences. Whether free glycine alone replicates this finding is unknown, but the collagen-bone relationship provides biologic plausibility for glycine's role.

Clinical Monitoring for Patients Taking Both

Routine monitoring for an alendronate-glycine combination does not require any additional lab panels beyond what osteoporosis management already demands.

Standard Osteoporosis Monitoring

The American Association of Clinical Endocrinology (AACE) 2020 Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis recommend dual-energy X-ray absorptiometry (DXA) every one to two years during active treatment, along with baseline and periodic serum calcium, 25-hydroxyvitamin D, and bone turnover markers such as serum CTX (C-terminal telopeptide) [14].

Adding glycine to this regimen does not change those monitoring recommendations. Serum glycine is not a clinically useful marker in this context.

When to Contact Your Prescriber

Patients should contact their prescribing clinician if they notice:

• Difficulty swallowing, chest pain, or heartburn after taking alendronate (signs of esophageal irritation, not related to glycine but common and serious) [3].
• New jaw pain or looseness of teeth (rare risk of osteonecrosis of the jaw with bisphosphonates, not related to glycine).
• Any unexplained thigh or groin pain (atypical femoral fractures associated with long-term bisphosphonate use) [15].

None of these adverse effects are caused or worsened by glycine supplementation based on current evidence.

Practical Dosing Guidance for Glycine with Alendronate

Alendronate Dosing Schedules

Alendronate is prescribed as:

• 70 mg once weekly (most common for treatment of postmenopausal osteoporosis).
• 35 mg once weekly (prevention).
• 10 mg once daily (less common, original approval dose).
• 70 mg oral solution (for patients who cannot swallow tablets) [3].

The dosing protocol is identical across formulations: first thing in the morning, plain water only, remain upright for at least 30 minutes.

Glycine Dosing Options

Typical supplemental glycine doses studied in clinical research:

• Sleep quality: 3 g taken 30 to 60 min before bedtime [8]. This evening timing completely sidesteps the alendronate absorption window.
• Collagen support / general amino acid use: 2.5 g to 5 g per day, divided or single dose, typically with meals.
• Glycemic support research doses: 5 g with meals, per the glycine-diabetes literature [9].

Taking glycine in the evening or with lunch or dinner is the cleanest strategy for weekly alendronate users. It avoids any theoretical absorption concern while preserving whatever benefits glycine may provide.

A Sample Weekly Schedule for a Fosamax User

On your alendronate day (e.g., every Monday morning):

1. Wake. Take 70 mg alendronate tablet with 240 mL plain water.
2. Remain upright (seated or standing) for 30 minutes.
3. At 30 to 60 minutes post-dose, normal breakfast including other supplements.
4. Evening: 3 g glycine powder in water before bed if using for sleep support.

On all other days, glycine can be taken at any time that fits your routine.

Safety Profile of Glycine at Supplement Doses

Glycine is classified as Generally Recognized As Safe (GRAS) by the FDA for use in food [16]. At doses up to 5 g per day, adverse effects in clinical trials are minimal. The most commonly reported effect is mild gastrointestinal softness at doses above 10 g per day. No hepatotoxicity, nephrotoxicity, or cardiovascular signals have emerged in the human trial literature at standard supplement doses.

Special Populations

• Chronic kidney disease (CKD): Amino acid metabolism generates nitrogenous waste. Patients with stage 3b CKD or lower (eGFR <45 mL/min/1.73m2) should discuss high-dose amino acid supplementation with their nephrologist. CKD independently complicates bone health and bisphosphonate use.
• Pregnancy and breastfeeding: Alendronate is FDA Pregnancy Category C (earlier classification) and is generally discontinued in women of childbearing potential. Glycine is a non-essential amino acid found in normal diet and is not contraindicated in pregnancy, though supplement data are limited.
• Pediatric patients: Alendronate is used off-label in pediatric osteogenesis imperfecta. Glycine safety in children at supplement doses has not been well-studied; avoid supplemental glycine in children unless directed by a physician.

What Clinicians and Guidelines Say

The AACE 2020 guidelines note that "adequate protein intake is essential to support bone matrix quality in patients receiving antiresorptive therapy" [14]. While the guidelines do not name glycine specifically, the underlying biology aligns: collagen-forming amino acids support the osteoid on which hydroxyapatite mineralizes, and bisphosphonates reduce the resorption that would otherwise remove that mineralized matrix.

Dr. Felicia Cosman, lead author of the National Osteoporosis Foundation's Clinician's Guide to Prevention and Treatment of Osteoporosis, has stated in the guideline document: "Dietary protein intake at the Recommended Dietary Allowance (0.8 g/kg/day) should be considered a minimum in patients with osteoporosis, with higher intakes evaluated individually" [17]. Glycine supplementation at 3 to 5 g per day adds a meaningful amino acid fraction without approaching toxicity thresholds.

Summary of Interaction Risk by Category

| Category | Risk Level | Notes | |---|---|---| | Pharmacokinetic (absorption) | Low-to-moderate if taken within 30 min | Separate by 30 to 60 min; risk resolves with timing | | Pharmacodynamic (bone mechanism) | No evidence of interaction | Different mechanisms; no antagonism identified | | Metabolic / glycemic | Negligible | Glycine may modestly improve insulin sensitivity | | Sleep / CNS | None adverse | Glycine may benefit sleep; no interaction with alendronate | | GI tolerability | None additional | Glycine does not worsen alendronate GI side effects | | Long-term bone outcomes | Potentially complementary | Collagen support may complement antiresorptive effect |